Technical analyst Rajesh Satpute maintained 'buy' rating on Divis Laboratories Limited stock for short term.

According to analyst, the stock can be bought with a stop loss of Rs 625 to attain a target of Rs 680.

The stock of the bank, on Feb 08, closed at Rs 645.45 on the Bombay Stock Exchange (BSE).

The share price has seen a 52-week high of Rs 797.70 and a low of Rs 562.80 on BSE.

Current EPS & P/E ratio stood at 29.49 and 21.70 respectively.

Divis Laboratories Lts has recorded an increase of 45% in its consolidated net profit for October-December period of 2010.

During the period under review, Divis Laboratories registered a net profit of Rs 984.2 million as against Rs 678.4 million for the corresponding period of 2009.

Company's total revenue grew by 54% in the said quarter to Rs 3,132 million as compared to Rs 2,039.9 million during the year-ago quarter.

On standalone basis, the company registered a net profit of 47.65% y-o-y for October-December period to Rs 1,015.7 million.

Company's total revenue increased 60% in the same quarter to Rs 3,139 million as against Rs 1,958.4 million for the corresponding period of 2009.

In another declaration, it said the execution of DSN SEZ plant at Visakhapatnam at an figured cost of Rs. 2 billion was moving ahead as per schedule.